A lot of work remains, but it’s exciting to see positive data on a drug candidate that may alter the course of Alzheimer’s disease.https://b-gat.es/2NnNysJ 

A lot of work remains, but it’s exciting to see positive data on a drug candidate that may alter the course of Alzheimer’s disease.https://b-gat.es/2NnNysJ